Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

polypharmacy

Patients’ perspectives on polypharmacy are highly personal, systematic review concludesSubscription

Healthcare professionals should actively seek to understand individual patients’ perspectives on polypharmacy and its challenges, research in BMJ Open has concluded.

girl with migraine

Fremanezumab safe and effective for preventing migraine over longer term, study suggestsSubscription

Patients with migraine continue to benefit from preventive treatment with fremanezumab over the longer term, with sustained reductions in monthly migraine and headache days, a study in Neurology has suggested.

ibuprofen tablets

Routine NSAID use not associated with poorer outcomes in patients hospitalised with COVID-19

Routine use of non-steroidal anti-inflammatory drugs might confer “modest” survival benefit for patients hospitalised with COVID-19 and is not associated with poorer outcomes, the results of a study published in the Journal of Clinical Medicine have suggested.

Carbapenem resistant bacteria acinetobacter spp

Cefiderocol effective for carbapenem-resistant Gram-negative infectionsSubscription

The clinical and microbiological outcomes of cefiderocol, a new antibiotic, were similar to the best available therapy for patients with life-threatening carbapenem-resistant infections, a phase III study has suggested.

covid 19 cough

Respiratory impairment persists for weeks post-discharge in hospitalised COVID-19 patients

Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.

Atopic dermatitis on hands

Addition of baricitinib to mainstay of treatment improves signs and symptoms of atopic dermatitis, study findsSubscription

Adding the oral selective Janus kinase 1 and 2 inhibitor, baricitinib, to topical corticosteroid treatment significantly improves the signs and symptoms of moderate-to-severe atopic dermatitis, a phase III study in JAMA Dermatology has suggested.

Montelukast asthma drug

Personalised medicine approach could benefit people with asthmaSubscription

Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.

blood-clot-artery-lipid-heart-attack-15

Gaps between clinical guidelines and practice for lipid management in Europe, researchers findSubscription

Less than 60% of patients receiving lipid-lowering therapy achieve the low-density lipoprotein cholesterol levels set out in European guidelines.

honey

Honey effective at relieving URTI symptoms, analysis concludesSubscription

Honey is superior to usual care for improving symptoms of upper respiratory tract infection symptoms, researchers have concluded.

More research briefings

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs